Your search returned 31 results.

Results
	1.	Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data. [electronic resource] by Trautmann, Michael E Han, Jenny Ruggles, James Producer: 20170918 In: Clinical therapeutics vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. [electronic resource] by Carpenter, Thomas Trautmann, Michael E Baron, Alain D Producer: 20051129 In: The New England journal of medicine vol. 353 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1. [electronic resource] by Parkes, David G Mace, Kenneth F Trautmann, Michael E Producer: 20130702 In: Expert opinion on drug discovery vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials. [electronic resource] by Trautmann, Michael E Van Gaal, Luc Han, Jenny Hardy, Elise Producer: 20180521 In: Journal of diabetes and its complications vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Exenatide once weekly for the treatment of type 2 diabetes. [electronic resource] by Malone, James Trautmann, Michael Wilhelm, Ken Taylor, Kristin Kendall, David M Producer: 20090618 In: Expert opinion on investigational drugs vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. [electronic resource] by DeYoung, Mary Beth MacConell, Leigh Sarin, Viren Trautmann, Michael Herbert, Paul Producer: 20120402 In: Diabetes technology & therapeutics vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years. [electronic resource] by Taylor, Kristin Gurney, Kate Han, Jenny Pencek, Richard Walsh, Brandon Trautmann, Michael Producer: 20110714 In: BMC endocrine disorders vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Assessment of pancreatic β-cell function: review of methods and clinical applications. [electronic resource] by Cersosimo, Eugenio Solis-Herrera, Carolina Trautmann, Michael E Malloy, Jaret Triplitt, Curtis L Producer: 20141118 In: Current diabetes reviews vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 study. [electronic resource] by Guerci, Bruno Trautmann, Michael E Lin, Tim Hardy, Elise Mudaliar, Sunder Raj D Producer: 20200907 In: Diabetes, obesity & metabolism vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. [electronic resource] by Diamant, Michaela Van Gaal, Luc Stranks, Stephen Northrup, Justin Cao, Dachuang Taylor, Kristin Trautmann, Michael Producer: 20100720 In: Lancet (London, England) vol. 375 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. [electronic resource] by Kim, Dennis MacConell, Leigh Zhuang, Dongliang Kothare, Prajakti A Trautmann, Michael Fineman, Mark Taylor, Kristin Producer: 20070613 In: Diabetes care vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Safety of exenatide once weekly in patients with type 2 diabetes mellitus treated with a thiazolidinedione alone or in combination with metformin for 2 years. [electronic resource] by Norwood, Paul Liutkus, Joanne F Haber, Harry Pintilei, Ella Boardman, Marilyn K Trautmann, Michael E Producer: 20130322 In: Clinical therapeutics vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. [electronic resource] by Rosenstock, Julio Klaff, Leslie J Schwartz, Sherwyn Northrup, Justin Holcombe, John H Wilhelm, Kenneth Trautmann, Michael Producer: 20100831 In: Diabetes care vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes. [electronic resource] by Blevins, Thomas Pullman, John Malloy, Jaret Yan, Ping Taylor, Kristin Schulteis, Christine Trautmann, Michael Porter, Lisa Producer: 20110630 In: The Journal of clinical endocrinology and metabolism vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects. [electronic resource] by Keller, Jutta Trautmann, Michael E Haber, Harry Tham, Lai San Hunt, Tamsin Mace, Kenneth Linnebjerg, Helle Producer: 20130322 In: Regulatory peptides vol. 179 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	N-2-pyridinylmethyl-N'-arylmethyl-diaminomaleonitriles: new highly selective chromogenic chemodosimeters for copper(II). [electronic resource] by Schwarze, Thomas Kelling, Alexandra Müller, Holger Trautmann, Michael Klamroth, Tillmann Baumann, Otto Strauch, Peter Holdt, Hans-Jürgen Producer: 20121212 In: Chemistry (Weinheim an der Bergstrasse, Germany) vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. [electronic resource] by Barnett, Anthony H Burger, Jude Johns, Don Brodows, Robert Kendall, David M Roberts, Anthony Trautmann, Michael E Producer: 20080220 In: Clinical therapeutics vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial. [electronic resource] by Wysham, Carol H MacConell, Leigh A Maggs, David G Zhou, Ming Griffin, Peter S Trautmann, Michael E Producer: 20150427 In: Mayo Clinic proceedings vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. [electronic resource] by Drucker, Daniel J Buse, John B Taylor, Kristin Kendall, David M Trautmann, Michael Zhuang, Dongliang Porter, Lisa Producer: 20090106 In: Lancet (London, England) vol. 372 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes. [electronic resource] by Yoon, Kun-Ho Kang, Jahoon Kwon, Se Chang Trautmann, Michael E Hompesch, Marcus Stewart, John Sorli, Christopher H Producer: 20210624 In: Diabetes, obesity & metabolism vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 31 results.